Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Moderate to high levels of pre-treatment HIV drug resistance in KwaZulu-Natal Province, South Africa.

Chimukangara B, Kharsany AB, Lessells RJ, Naidoo K, Rhee SY, Manasa J, Gräf T, Lewis L, Cawood C, Khanyile D, Diallo K, Ayalew KA, Shafer R, Hunt G, Pillay D, Abdool SK, de Oliveira T.

AIDS Res Hum Retroviruses. 2018 Nov 15. doi: 10.1089/AID.2018.0202. [Epub ahead of print]

PMID:
30430843
2.

Completeness of patient-held records: observations of the Road-to-Health Booklet from two national facility-based surveys at 6 weeks postpartum, South Africa.

Ramraj T, Goga AE, Larsen A, Ramokolo V, Bhardwaj S, Chirinda W, Jackson D, Nsibande D, Ayalew K, Pillay Y, Lombard CJ, Ngandu NK; South Africa PMTCT Evaluation (SAPMCTE) Team.

J Glob Health. 2018 Dec;8(2):020901. doi: 10.7189/jogh.08.020901.

3.

Use of PRO Measures to Inform Tolerability in Oncology Trials: Implications for Clinical Review, IND Safety Reporting, and Clinical Site Inspections.

Kim J, Singh H, Ayalew K, Borror K, Campbell M, Johnson LL, Karesh A, Khin NA, Less JR, Menikoff J, Minasian L, Mitchell SA, Papadopoulos EJ, Piekarz RL, Prohaska KA, Thompson S, Sridhara R, Pazdur R, Kluetz PG.

Clin Cancer Res. 2018 Apr 15;24(8):1780-1784. doi: 10.1158/1078-0432.CCR-17-2555. Epub 2017 Dec 13.

PMID:
29237718
4.

Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura.

Jamali F, Lemery S, Ayalew K, Robottom S, Robie-Suh K, Rieves D, Pazdur R.

Oncology (Williston Park). 2009 Jul;23(8):704-9.

5.

Carbapenems in pediatrics.

Ayalew K, Nambiar S, Yasinskaya Y, Jantausch BA.

Ther Drug Monit. 2003 Oct;25(5):593-9. Review.

PMID:
14508383

Supplemental Content

Loading ...
Support Center